561. Safety of Remdesivir vs Standard Care in Patients with Moderate Covid-19

BACKGROUND: Remdesivir (RDV) has been shown to shorten recovery time and was well tolerated in patients with severe COVID-19. Here we report safety of RDV in patients with moderate COVID-19. METHODS: We conducted an open-label, phase 3 trial (NCT04252664) in hospitalized patients with confirmed SARS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Criner, Gerard J, Ahn, Mi Young, Huhn, Gregory, Subramanian, Aruna, Lumbreras, Carlos, Schmiedel, Stefan, Hyland, Robert H, Suri, Vithika, Cao, Huyen, Wang, Hongyuan, SenGupta, Devi, Chokkalingam, Anand, Osinusi, Anu, Brainard, Diana M, Chen, Yao-Shen, Günthard, Huldrych, Sanz-Moreno, D Jose, Aberg, Judith A, Nicastri, Emanuele, Tsang, Owen Tak-Yin
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Poster Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7777368/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa439.755
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados